SUNISAM 50MG CAP
Prescription Required
Sale price
₹ 1,900.00
Regular price
MRP: ₹ 3,250.00
42% OFF
Inclusive of all taxes.
Couldn't load pickup availability
SUNISAM 50MG CAP
Regular price
₹ 1,900.00
Regular price
₹ 3,250.00
Sale price
₹ 1,900.00
(-42%)
Unit price
per
SUNISAM 50MG CAP
Sale price
₹ 1,900.00
Regular price
MRP: ₹ 3,250.00
42% OFF
- Introduction
- Uses
- Storage
- Safety
- Side effects
- Abouts RareMeds
- Disclaimer
Introduction
Sunisam 50mg Capsule contains sunitinib, a multi-targeted tyrosine kinase inhibitor that blocks tumour growth and angiogenesis.
Uses
Sunisam 50mg Capsule is used for the treatment of advanced kidney cancer, gastrointestinal stromal tumours (GIST) and pancreatic neuroendocrine tumours.
- Renal cell carcinoma
- Gastrointestinal stromal tumour (GIST)
- Pancreatic neuroendocrine tumours
Storage
- Store below 30°C.
- Keep in a cool, dry place away from moisture.
Safety Information
- Monitor blood pressure, thyroid function, liver function and complete blood counts regularly.
Possible Side Effects
Possible side effects may include:
- Fatigue
- Diarrhoea
- High blood pressure (hypertension)
- Hand-foot syndrome
- Nausea
- Mouth ulcers
About RareMeds
We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.
The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.
No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.
Disclaimer
Sunisam is a prescription targeted anticancer medicine.
It should only be used under the supervision of a qualified oncologist.